{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T19:10:21Z","timestamp":1735585821104,"version":"3.32.0"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Lung adenocarcinoma (LUAD) is the most common histological subtype of lung cancer, characterized by a high incidence in late stages, high mortality rate, and poor prognosis. Src Homology 2 Domain Containing Protein 5 (SH2D5) is a mammalian-specific, uncharacterized scaffolding protein, and its role in LUAD remains unclear. In the present study, we investigated the function and potential mechanisms of SH2D5 in the progression of LUAD. We found aberrant expression of SH2D5 in LUAD tissues and cells, and its high expression is closely associated with poor prognosis in LUAD patients. Through loss-of-function and gain-of-function experiments, we revealed that overexpression of SH2D5 promotes the proliferation and migration abilities of lung adenocarcinoma cells. Gene set enrichment analysis (GSEA) revealed that SH2D5 positively regulates the epithelial-mesenchymal transition (EMT) process in lung adenocarcinoma cells. Additionally, we found that regulating the expression of SH2D5 influenced the phosphorylation levels of AKT, and the rescue experiments with AKT pathway activators\/inhibitors partially reversed the tumor progression and EMT processes induced by SH2D5. In summary, our study demonstrated that SH2D5 promotes the migration and EMT process of LUAD cells through the AKT signaling pathway, suggesting that SH2D5 may serve as a crucial potential target for the treatment of metastatic LUAD.<\/jats:p>","DOI":"10.1371\/journal.pone.0316432","type":"journal-article","created":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T18:29:38Z","timestamp":1735583378000},"page":"e0316432","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["SH2D5 promotes lung adenocarcinoma cell metastasis and triggers EMT via activating AKT signaling pathway"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-0279-378X","authenticated-orcid":true,"given":"Licheng","family":"Du","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjia","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linjun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haojia","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yubai","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2024,12,30]]},"reference":[{"key":"pone.0316432.ref001","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","author":"F Bray","year":"2024","journal-title":"CA Cancer J Clin."},{"issue":"7","key":"pone.0316432.ref002","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMoa1916623","article-title":"The Effect of Advances in Lung-Cancer Treatment on Population Mortality","volume":"383","author":"N Howlader","year":"2020","journal-title":"N Engl J Med"},{"issue":"20","key":"pone.0316432.ref003","doi-asserted-by":"crossref","first-page":"e2206744","DOI":"10.1002\/advs.202206744","article-title":"m6 A-Dependent Modulation via IGF2BP3\/MCM5\/Notch Axis Promotes Partial EMT and LUAD Metastasis","volume":"10","author":"X Yang","year":"2023","journal-title":"Adv Sci (Weinh)."},{"issue":"10066","key":"pone.0316432.ref004","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0140-6736(16)30958-8","article-title":"Lung cancer: current therapies and new targeted treatments","volume":"389","author":"FR Hirsch","year":"2017","journal-title":"Lancet"},{"issue":"17","key":"pone.0316432.ref005","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1200\/JCO.2017.77.0412","article-title":"Five-Year Follow-Up of Nivolumab in Previously Treated Advanced Non-Small-Cell Lung Cancer: Results From the CA209-003 Study.","volume":"36","author":"S Gettinger","year":"2018","journal-title":"J Clin Oncol."},{"issue":"11","key":"pone.0316432.ref006","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1158\/2159-8290.CD-21-1658","article-title":"The Single-Cell Immunogenomic Landscape of B and Plasma Cells in Early-Stage Lung Adenocarcinoma.","volume":"12","author":"D Hao","year":"2022","journal-title":"Cancer Discov"},{"issue":"1","key":"pone.0316432.ref007","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41556-018-0196-y","article-title":"Non-redundant functions of EMT transcription factors","volume":"21","author":"MP Stemmler","year":"2019","journal-title":"Nat Cell Biol"},{"key":"pone.0316432.ref008","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1146\/annurev-cellbio-092910-154036","article-title":"The ins and outs of the epithelial to mesenchymal transition in health and disease","volume":"27","author":"MA Nieto","year":"2011","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"6","key":"pone.0316432.ref009","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41580-020-0237-9","article-title":"Guidelines and definitions for research on epithelial-mesenchymal transition","volume":"21","author":"J Yang","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"pone.0316432.ref010","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13045-022-01347-8","article-title":"The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis.","volume":"15","author":"Y Huang","year":"2022","journal-title":"J Hematol Oncol"},{"issue":"4","key":"pone.0316432.ref011","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/med.21948","article-title":"Mechanism of epithelial-mesenchymal transition in cancer and its regulation by natural compounds","volume":"43","author":"HL Ang","year":"2023","journal-title":"Med Res Rev"},{"issue":"1","key":"pone.0316432.ref012","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41392-022-01132-6","article-title":"Classical epithelial-mesenchymal transition (EMT) and alternative cell death process-driven blebbishield metastatic-witch (BMW) pathways to cancer metastasis.","volume":"7","author":"GG Jinesh","year":"2022","journal-title":"Signal Transduct Target Ther."},{"issue":"5","key":"pone.0316432.ref013","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1084\/jem.20181827","article-title":"Context-dependent EMT programs in cancer metastasis","volume":"216","author":"NM Aiello","year":"2019","journal-title":"J Exp Med"},{"issue":"8","key":"pone.0316432.ref014","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s41419-023-06032-3","article-title":"The role of epithelial-mesenchymal transition and autophagy in pancreatic ductal adenocarcinoma invasion","volume":"14","author":"J Yang","year":"2023","journal-title":"Cell Death Dis"},{"key":"pone.0316432.ref015","doi-asserted-by":"crossref","first-page":"114395","DOI":"10.1016\/j.biopha.2023.114395","article-title":"Unraveling the function of epithelial-mesenchymal transition (EMT) in colorectal cancer: Metastasis, therapy response, and revisiting molecular pathways.","volume":"160","author":"E Sabouni","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"pone.0316432.ref016","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1146\/annurev-pathmechdis-051222-122423","article-title":"Update on Epithelial-Mesenchymal Plasticity in Cancer Progression.","volume":"19","author":"R Fontana","year":"2024","journal-title":"Annu Rev Pathol"},{"key":"pone.0316432.ref017","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.biochi.2019.08.003","article-title":"Role of AKT and mTOR signaling pathways in the induction of epithelial-mesenchymal transition (EMT) process.","volume":"165","author":"M Karimi Roshan","year":"2019","journal-title":"Biochimie"},{"issue":"1","key":"pone.0316432.ref018","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s13046-022-02377-3","article-title":"TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K\/AKT pathway in bladder cancer","volume":"41","author":"M Chi","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"pone.0316432.ref019","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41388-023-02847-8","article-title":"USP11 potentiates HGF\/AKT signaling and drives metastasis in hepatocellular carcinoma","volume":"43","author":"J Chen","year":"2024","journal-title":"Oncogene"},{"issue":"51","key":"pone.0316432.ref020","doi-asserted-by":"crossref","first-page":"35397","DOI":"10.1074\/jbc.M114.615112","article-title":"Src homology 2 domain containing protein 5 (SH2D5) binds the breakpoint cluster region protein, BCR, and regulates levels of Rac1-GTP.","volume":"289","author":"EJ Gray","year":"2014","journal-title":"J Biol Chem"},{"issue":"202","key":"pone.0316432.ref021","first-page":"ra83","article-title":"The SH2 domain-containing proteins in 21 species establish the provenance and scope of phosphotyrosine signaling in eukaryotes.","volume":"4","author":"BA Liu","year":"2011","journal-title":"Sci Signal."},{"issue":"13","key":"pone.0316432.ref022","doi-asserted-by":"crossref","first-page":"4815","DOI":"10.1074\/jbc.RA118.005739","article-title":"Hepatitis B virus X protein-induced SH2 domain-containing 5 (SH2D5) expression promotes hepatoma cell growth via an SH2D5-transketolase interaction.","volume":"294","author":"Y Zheng","year":"2019","journal-title":"J Biol Chem"},{"key":"pone.0316432.ref023","doi-asserted-by":"crossref","first-page":"e15238","DOI":"10.7717\/peerj.15238","article-title":"Prognostic significance of SH2D5 expression in lung adenocarcinoma and its relation to immune cell infiltration","volume":"11","author":"H Zhou","year":"2023","journal-title":"PeerJ"},{"issue":"2","key":"pone.0316432.ref024","article-title":"An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics","volume":"173","author":"J Liu","year":"2018","journal-title":"Cell"},{"issue":"20","key":"pone.0316432.ref025","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1101\/gad.225334.113","article-title":"Epithelial-mesenchymal plasticity in carcinoma metastasis","volume":"27","author":"JH Tsai","year":"2013","journal-title":"Genes Dev"},{"key":"pone.0316432.ref026","doi-asserted-by":"crossref","first-page":"101364","DOI":"10.1016\/j.tranon.2022.101364","article-title":"The PI3K\/Akt\/mTOR pathway in lung cancer; oncogenic alterations, therapeutic opportunities, challenges, and a glance at the application of nanoparticles.","volume":"18","author":"M-J Sanaei","year":"2022","journal-title":"Transl Oncol."},{"issue":"3","key":"pone.0316432.ref027","first-page":"1523","article-title":"Antitumor activity of curcumin by modulation of apoptosis and autophagy in human lung cancer A549 cells through inhibiting PI3K\/Akt\/mTOR pathway.","volume":"39","author":"F Liu","year":"2018","journal-title":"Oncol Rep."},{"key":"pone.0316432.ref028","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.pharmthera.2019.02.010","article-title":"Nanotechnology in the diagnosis and treatment of lung cancer","volume":"198","author":"AM Cryer","year":"2019","journal-title":"Pharmacol Ther"},{"issue":"10","key":"pone.0316432.ref029","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.tcb.2020.07.003","article-title":"EMT, MET, Plasticity, and Tumor Metastasis","volume":"30","author":"B Bakir","year":"2020","journal-title":"Trends Cell Biol"},{"issue":"19","key":"pone.0316432.ref030","doi-asserted-by":"crossref","first-page":"19850","DOI":"10.1002\/cam4.6566","article-title":"UBE2V2 promotes metastasis by regulating EMT and predicts a poor prognosis in lung adenocarcinoma","volume":"12","author":"Z Yang","year":"2023","journal-title":"Cancer Med"},{"issue":"7","key":"pone.0316432.ref031","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/s41416-020-01250-4","article-title":"EEF1A2 interacts with HSP90AB1 to promote lung adenocarcinoma metastasis via enhancing TGF-\u03b2\/SMAD signalling","volume":"124","author":"L Jia","year":"2021","journal-title":"Br J Cancer"},{"issue":"1","key":"pone.0316432.ref032","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","author":"A Glaviano","year":"2023","journal-title":"Mol Cancer"},{"issue":"9","key":"pone.0316432.ref033","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1002\/jcp.31087","article-title":"Multiple forms of cell death: A focus on the PI3K\/AKT pathway","volume":"238","author":"J Xu","year":"2023","journal-title":"J Cell Physiol"},{"issue":"8","key":"pone.0316432.ref034","doi-asserted-by":"crossref","first-page":"e522","DOI":"10.1002\/ctm2.522","article-title":"Apolipoprotein C-II induces EMT to promote gastric cancer peritoneal metastasis via PI3K\/AKT\/mTOR pathway.","volume":"11","author":"C Wang","year":"2021","journal-title":"Clin Transl Med."},{"issue":"1","key":"pone.0316432.ref035","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.1038\/s41467-020-18929-0","article-title":"AKT-induced lncRNA VAL promotes EMT-independent metastasis through diminishing Trim16-dependent Vimentin degradation.","volume":"11","author":"H Tian","year":"2020","journal-title":"Nat Commun"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0316432","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T18:29:47Z","timestamp":1735583387000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0316432"}},"subtitle":[],"editor":[{"given":"Zhiming","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2024,12,30]]},"references-count":35,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0316432","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,30]]}}}